Lung Cancer 2021, Part 1, An Issue of Thoracic Surgery Clinics
- 1st Edition, Volume 31-3 - August 6, 2021
- Latest edition
- Editor: Farid M. Shamji
- Language: English
In this issue of Thoracic Surgery Clinics, guest editor Farid Shamji brings considerable expertise to the topic of Lung Cancer.… Read more
Purchase options
In this issue of Thoracic Surgery Clinics, guest editor Farid Shamji brings considerable expertise to the topic of Lung Cancer.
- Provides in-depth, clinical reviews on Lung Cancer, providing actionable insights for clinical practice.
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field; Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.
How to Design and Foster Thoracic Oncology Multidisciplinary Cancer Conferences
Guiding Principles in the Management of Synchronous and Metachronous Primary Non–Small Cell Lung Cancer
When Is It Safe to Operate for Lung Cancer? Selection of Fiscally Responsible Cardiopulmonary Function Tests for Limited Resection (Wedge Resection and Segmentectomy), Standard Lobectomy, Sleeve Lobectomy, and Pneumonectomy
Management of Air Leaks and Residual Spaces Following Lung Resection
Extended Pulmonary Resection by Sleeve Lobectomy and Carinal Pneumonectomy: Selection and Technique
Role of the Thoracic Radiologist in the Evaluation and Management of Solid and Subsolid Lung Nodules
Recognition and Management of Acute and Late Complications of Pneumonectomy: Clinical Cases and Treatment
Constants and Currents in the Education and Training of General Thoracic Surgeons
Assessment and Rehabilitation of the Compromised Patient Prior to Thoracotomy
Is Small Cell Lung Cancer a Surgical Disease at the Present Time?
Embolotherapy in Bronchial Hemorrhage
Ethics for Thoracic Surgeons in the Management of Lung Cancer
Oligometastatic Lung Cancer Defined by Biology, Science, and Secondary Growths
Implications of Adverse Biological Factors and Management of Solitary Fibrous Tumors of the Pleura
Can Biologic Aggressiveness and Metastatic Potential of Primary Lung Cancer Be Predicted from Clinical Staging Alone?
Guiding Principles in the Management of Synchronous and Metachronous Primary Non–Small Cell Lung Cancer
When Is It Safe to Operate for Lung Cancer? Selection of Fiscally Responsible Cardiopulmonary Function Tests for Limited Resection (Wedge Resection and Segmentectomy), Standard Lobectomy, Sleeve Lobectomy, and Pneumonectomy
Management of Air Leaks and Residual Spaces Following Lung Resection
Extended Pulmonary Resection by Sleeve Lobectomy and Carinal Pneumonectomy: Selection and Technique
Role of the Thoracic Radiologist in the Evaluation and Management of Solid and Subsolid Lung Nodules
Recognition and Management of Acute and Late Complications of Pneumonectomy: Clinical Cases and Treatment
Constants and Currents in the Education and Training of General Thoracic Surgeons
Assessment and Rehabilitation of the Compromised Patient Prior to Thoracotomy
Is Small Cell Lung Cancer a Surgical Disease at the Present Time?
Embolotherapy in Bronchial Hemorrhage
Ethics for Thoracic Surgeons in the Management of Lung Cancer
Oligometastatic Lung Cancer Defined by Biology, Science, and Secondary Growths
Implications of Adverse Biological Factors and Management of Solitary Fibrous Tumors of the Pleura
Can Biologic Aggressiveness and Metastatic Potential of Primary Lung Cancer Be Predicted from Clinical Staging Alone?
- Edition: 1
- Latest edition
- Volume: 31-3
- Published: August 6, 2021
- Language: English
FS
Farid M. Shamji
Affiliations and expertise
Cardiothoracic Surgeon, Ottawa Ontario Canada